Uniting the Best Scientists in Quebec to Find Solutions to Cancer

The Cancer Research Society contributes 1.5 million dollars to the Oncopole to help finance exceptional research projects with the potential to make a difference in the prevention, diagnostic, and treatment of this disease

Montreal, February 6, 2018 — The Cancer Research Society is proud to announce a contribution of 1.5 million dollars to Oncopole for its EMC2 competition whose goal is to finance cooperative research projects in order to capitalize on the expertise and strengths to be found in the province of Quebec in the field of oncology. The competition’s goal is to encourage collaboration between researchers in various fields, from different Quebec institutions, in order to have a greater impact on the disease.

“Research is our best weapon to outsmart a disease as complex as cancer. And when the best researchers work in collaboration, the potential is incredible,” explains Max Fehlmann, President and Chief Executive Officer of the Cancer Research Society. “It was therefore only natural for us to support such a mobilizing competition established by Oncopole which will help maximize our donors’ investments by accelerating the development of new tools to prevent, diagnose and conquer all types of cancer.”

It was last November that Oncopole, a new initiative supported by the Fonds de recherche du Québec – Santé (FRQS) and Merck Canada Inc., launched the EMC2 competition within the scientific community in Quebec. More than fifty teams were invited to submit complete applications. “We were delighted by the amount of interest generated by our first call for proposals, which confirmed the enthusiasm for oncology research in Quebec and the desire to have a more significant impact on the disease to the benefit of patients,” indicated Stéphanie Lord-Fontaine, Executive Director at Oncopole. “We are very happy to be able to count upon support from the Cancer Research Society, our first philanthropic partner. This announcement substantiates the catalyzing role of Oncopole and its vision to make Quebec a centre for excellence and investment in cancer research.”

With the participation of the Cancer Research Society, the program’s budget amounts to 7.5 million dollars over the course of three years. “The amounts invested are considerable and we anticipate important benefits in the form of major discoveries and scientific advances. We wholeheartedly hope that this partnership model will inspire others across the country,” concludes Max Fehlmann.

About the Cancer Research Society

Founded in 1945, the Cancer Research Society is the first Canadian organization entirely dedicated to funding research on all types of cancer. Over the course of its history, the CRS has supported thousands of our country’s best scientific minds who have helped make important strides in the way we prevent, detect, and treat cancer. Since 2000, thanks to the generosity of donors across the country, the CRS distributed over $140 million in research grants. For more information: CancerResearchSociety.ca

About the Oncopole

The Oncopole is a Quebec hub for research, development and investment to accelerate the fight against cancer. Created in February of 2017, it is the product of a unique co-creation process led by the Fonds de recherche du Québec – Santé (FRQS) and made possible by an initial $15M investment from Merck Canada. The Oncopole’s mission is to act as a catalyst leveraging actions made by the key players in Quebec’s oncology and innovation research ecosystem. As a result, it aims to position the province as a leader in the field. Its priorities of action, namely research, entrepreneurship, commercialization and integration of innovation, as well as clinical relevance, are orchestrated in order to foster the mobilization of stakeholders, the discovery of innovative approaches to fight cancer and, ultimately, a positive impact for the benefit of patients. For more information, go to: oncopole.ca

– 30 –

Sources: Cancer Research Society and Oncopole


Carolyne Lord

Director, Communications and Marketing | Cancer Research Society

514-861-9227, ext. 270



Catherine Cardinal

514-343-3111, ext. 41299




The Oncopole and IRICoR have joined forces to launch the Scholarship Competition – Entrepreneurship in Oncology (CEO), offering the next generation of scientists an opportunity to develop their entrepreneurial skills, along with their academic skills. Thus, both organizations will offer training scholarships, as part of the new Life Sciences Entrepreneurship Development Program, created through a partnership between Montréal InVivo, Université de Montréal’s Faculty of Pharmacy and Concordia University’s John Molson Executive Centre, in collaboration with IRICoR.


This practical and immersive training, the result of a joint effort between key players in life sciences from both industry and academia, will allow you to familiarize yourself with the development stages of an innovative company, from the lab to the market, through current management models that apply to both the research and the commercialization of innovation stages.


  • The program includes 9 intensive 2- to 3-day modules (Friday and Saturday, once a month, classes taught in Montreal) from March, 2018, to January, 2019, in order to allow you to gradually apply the knowledge acquired to the challenges you face on a daily basis.
  • Furthermore, by taking part in this first cohort limited to about thirty candidates, you will be contributing to the progression of a tangible project with other participants from various backgrounds, thus allowing you to forge links with different players in the life science sector.

For more information, go to:



The Oncopole and IRICoR want to ensure the training of the next generation of scientists through better tools for project management and entrepreneurial skills. Both organizations aim to identify the most promising candidates in the ecosystem and make it easier for them to get a training that meets their needs.


PhD candidates (at least 3 years completed), Postdoctoral Fellows and Young Investigators (Research Scholars – Junior 1 and Junior 2) (prior to tenure) affiliated with a Canadian teaching or research institution at application submission, are eligible.

*Please note that the Oncopole can only support Québec candidates.


The scholarship amount awarded to each recipient will cover the full program registration fees, namely $5,890 + taxes. Furthermore, applicants residing outside the Montreal metropolitan area could be reimbursed for part of their travel and accommodation costs related to having participated in the program.


Applicants must fill out the form (attached or below) and send it to audrey.segret@umontreal.ca, by February 7, 2018, at 5:00pm. The applicants can also contact Audrey for any question on the competition.

Applicants will be informed of the results by March 1, 2018. Applications will be assessed according to the following scorecard:

Scoring Sections Criteria
1. Applicant information
15% 2. Research experience: 50 words – Relevance of the oncology research project 100 words – Academic distinction 100 words – Scientific communication Activities and achievements to date
35% 3. Previous entrepreneurial experience: 300 words – Relevance of previous entrepreneurial experience (3 max.) 500 words – Demonstration of the applicant’s sense of entrepreneurship General characteristics and skills

Entrepreneurial experience and skills demonstrated

50% 4. Motivation: 500 words – Motivation to join the program 250 words – Expectations with respect to the program Potential shown

Alignment of program/career goals


  • Make sure to download and save the document onto your computer in order to fill it out.
  • Please title the document as follows: Last name_application form_CEO, then send it to audrey.segret@umontreal.ca, by February 7, 2018, 5:00pm.
  • The document must be sent in PDF format.


By submitting his/her application, the applicant must agree:

  • To attend all sessions of the Life Sciences Entrepreneurship Development Program.
  • Following completion of the program, to provide the Oncopole and IRICoR with his/her assessment of said program and of the competition; this assessment to be done when and how the Oncopole and IRICoR deem fit (e.g. meeting, report, form, etc.).
  • To authorize the Oncopole and IRICoR to keep and to use all of the information contained in its file provided that all personal information will remain confidential.

For more information about the Life Sciences Entrepreneurship Development Program, please contact:

Valérie Lancelot-Mingot
Programs Manager
John Molson School of Business
514 848-3960

About the Oncopole

The Oncopole is Quebec’s hub for research, development and investment to accelerate the fight against cancer. Created in February of 2017, it is the product of a unique co-creation process led by the Fonds de recherche du Québec – Santé (FRQS) and made possible by an initial $15M investment from Merck Canada. The Oncopole’s mission is to act as a catalyst leveraging actions made by the key players in Quebec’s oncology and innovation research ecosystem. As a result, it aims to position the province as a leader in the field. Its priorities of action, namely research, entrepreneurship, commercialization and integration of innovation, as well as clinical relevance, are orchestrated in order to foster the mobilization of stakeholders, the discovery of innovative approaches to fight cancer and, ultimately, a positive impact for the benefit of patients. For more information about Oncopole, go to: oncopole.ca

About the Institute for Research in Immunology and Cancer – Commercialization of Research (IRICoR)

As Université de Montréal’s drug discovery and project maturation cluster, IRICoR is a not-for-profit organization based at the Institute for Research in Immunology and Cancer (IRIC), with the mandate to accelerate the discovery, development and commercialization of novel therapies in cancer, immunotherapy and related fields. Since its creation in 2008, IRICoR successfully invests in and supports cutting-edge projects with disruptive potential to rapidly translate innovation into patient-accessible therapies, through either co-development partnerships with industry or company creation. IRICoR seamlessly integrates business-related expertise with industry-level drug discovery in a world-renowned research institute, providing academics with access to a full drug discovery chain with one of the largest academia-based medicinal chemistry groups in Canada. For more information about IRICoR, go to: iricor.ca

The Oncople is looking for a Project Manager (Focus 2- Entrepreneurship and Promotion of Innovation)

Description du poste

Référence : Offre no. 508204

Merck Canada Inc. et le Fonds de recherche du Québec – Santé (FRQS) ont uni leurs forces pour mettre de l’avant l’Oncopole, un projet novateur qui vise à consolider l’écosystème de recherche et d’innovation en cancer du Québec. Pour ce faire, une injection importante de ressources financières en soutien à des activités structurantes est prévue au courant des prochaines années, et ce, sur l’ensemble du continuum de recherche et d’innovation. L’objectif est de créer un cadre provincial collaboratif et avant-gardiste sur la recherche et l’innovation centré sur le patient.

Description du mandat

Relevant de la directrice générale, le gestionnaire de projet sera responsable de l’exécution du plan stratégique en lien avec les priorités définies pour l’axe 2- Entrepreneuriat et valorisation de l’innovation.

Principaux défis

  • Coordonner l’exécution des activités de l’axe 2- Entrepreneuriat et valorisation de l’innovation
  • Participer au comité de gestion et coordonner les activités du Groupe de travail de l’axe 2
  • Soutenir et orienter les chercheurs dans leur projet de valorisation et dans l’accès aux infrastructures et ressources disponibles
  • Coordonner la mise en place d’un programme de formation en entrepreneuriat
  • Former et animer un comité conseil formé d’experts en maturation/valorisation
  • Coordonner le lancement d’appel à projets pour l’axe 2 et participer au suivi des projets financés
  • Soutenir la mise en place de contrats spécifiques en lien avec les objectifs de l’axe
  • Rendre compte de l’état d’avancement des initiatives et présenter les divers rapports requis aux parties prenantes
  • Assurer le contrôle et le suivi du budget, prévoir les dépenses tout en s’assurant du respect des échéances.
  • Établir et maintenir la communication avec les différents collaborateurs internes et externes.
  • Contribuer à la coordination d’évènements/ateliers en lien avec l’axe
  • Participer à une veille stratégique des réalisations en oncologie au Québec
  • Assurer la liaison avec l’équipe des communications en lien avec les activités de l’axe​

Profil recherché

  • Diplôme universitaire de maîtrise dans un champ de spécialisation approprié ou un diplôme universitaire terminal de premier (1er) cycle dans un champ de spécialisation approprié et deux (2) années d’expérience pertinente au projet de recherche. Des habiletés ou des expertises spécialisées peuvent être exigées.

Autres habiletés et expertises :

  • Diplôme d’études supérieures en sciences de la vie (atout)
  • Expérience en commercialisation / transfert technologique;
  • Plus de cinq (5) années d’expérience en valorisation de l’innovation et/ou bio-pharmaceutique;
  • Connaissance en développement des affaires et gestion de projet;
  • Connaissance du milieu de la recherche en oncologie et de l’innovation en santé;
  • Excellente capacité d’analyse et de synthèse;
  • Excellente communication et maîtrise des langues française et anglaise (oral et écrit);
  • Autonomie, créativité et sens de l’organisation.

Information sur l’emploi

  • Syndicat des employés et employées de la recherche de l’Université de Montréal
  • Période d’affichage: Du 11 au 25 janvier 2018 inclusivement
  • Échelle salariale: R2 – de 49 788 $ à 71 550 $
  • Horaire de travail : 9h à 17h du lundi au vendredi
  • Date d’entrée en fonction: Le plutôt possible

Notre offre

  • Perspective de carrière diversifiée et intéressante.
  • Programme complet d’avantages sociaux et régime de retraite.
  • Politique avantageuse de vacances annuelles
  • Accès facile en transport collectif.

Niveau hiérarchique

  • Confirmé


  • Enseignement supérieur

Type d’emploi

  • Temps plein


  • Gestion
  • Management de projet


The Oncopole would like to congratulate the 56 teams invited to submit a full application to the Oncopole EMC2 competition. We are very pleased by the great interest for this first call for proposals proving the dynamism of oncology research in Québec.

We invite you to consult the list.

Since interdisciplinary and multi-institutional work is one of the objectives of the competition, projects’ and team consolidation is encouraged.

For more details on the competition: oncopole.ca/oncopole-emc2-first-call-for-proposals-on-the-oncopole?lang=en

Call for proposals              

Oncopole EMC2: Équipes multi-institutionnelles contre le cancer
(multi-institutional teams against cancer)             

The Oncopole, in partnership with the FRQS, is pleased to announce the launch of its first Call for proposals. This competition aims to support collaborative and structuring research projects that will build on Québec’s expertise and strengths in oncology.

By fostering collaboration between disciplines and institutions, the Oncopole wants to support the mobilization of Québec’s key players in order to tackle the public health challenge that cancer represents.

The power of collaboration

The teams must be interdisciplinary and made up of investigators from at least three institutions, research centers and institutes, or departments affiliated to a minimum of two Québec universities. The team may be composed of a maximum of three Principal Investigators and a minimum of four co-Investigators.

Research areas

Interdisciplinary research projects may focus on prevention, diagnosis or treatment, and be at the discovery stage, translational or preclinical research, early clinical research or evaluative research. Clinical trials that would normally only be funded by the industry are not eligible.

The program is open to all types of cancer. Projects must clearly align with a clinical need.

Program budget: $6M

Amount of the grant: maximum of $1.5M over 3 years. Co-funding is not mandatory.

Important dates

Deadline for submitting the notice of intent: November 24, 2017, 4:30 pm

Deadline for submitting the complete application: March 12, 2018, 4:30 pm

To access the program rules click here.

For more information on the proposal, please contact Manon Pelletier, Program Manager at FRQS.

For more information about the Oncopole, please contact Maxime Dumais, Program Manager at Oncopole

N.B.  Conference call information sessions about this Program will be held on October 30 (in French) and November 1 (in English).

Conference call: 514-736-8030 or 1-866-500-7802, access #: 1362430

PowerPoint presentation access: